Literature DB >> 23615693

Therapeutics: turnover.

Nicola McCarthy.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23615693     DOI: 10.1038/nrc3528

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Doxorubicin enhances nucleosome turnover around promoters.

Authors:  Fan Yang; Christopher J Kemp; Steven Henikoff
Journal:  Curr Biol       Date:  2013-04-18       Impact factor: 10.834

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.